View monthly record counts
| Month | Records |
|---|---|
| 225 | |
| 98 |
Data updated:
| Month | Records |
|---|---|
| 225 | |
| 98 |
| # | Country / Region | Records |
|---|---|---|
| 1 | United States | 142 |
| 2 | Germany | 51 |
| 3 | Italy | 19 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300490 | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装 | Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | 199 |
| 2 | 300432 | 含有皮质甾类激素及其衍生物或结构类似物的药品,已配定剂量或制成零售包装 | Medicaments containing corticosteroid hormones, their derivatives or structural analogues | 32 |
| 3 | 300439 | 未列名含有激素或品目29.37其他产品的药品,已配定剂量或制成零售包装 | Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excluding medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues) | 14 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | ASTRAZENECA UK LIMITED | UNITED STATES | 142 |
| 2 | ASTRAZENECA UK LTD | — | 60 |
| 3 | ASTRAZENECA AB | GERMANY | 51 |
| Date | Dec 10, 2025 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | ASTRAZENECA UK LIMITED | Buyer Information | Company Name | ASTRAZENECA DO BRASIL LTDA |
| Address | 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMED, S/N, CAMPUS - CAMBRIDGE CB, CAMBRIDGE-REINO UNIDO | Address | RAPOSO TAVARES, SN, KM 26.9, GRANJA VIANA, CEP: 06707000 - COTIA, SP - 11 37371200 | ||
| Registration No. | — | Registration No. | 60 318 797 0001 00 | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30049049 | HS Description | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | |
| Product Description | CODIGO SAP 100009004 - XIGDUO XR TAB 10MG/1000MG 5BLPX6 BR - PRODUTO: XIGDUO XR. MEDICAMENTO ACONDICIONADO PARA VENDA A RETALHO, COM NOME COMERCIAL DE "XIGDUO XR" COM SUBSTANCIAS ATIVAS DAPAGLIFLOZINA (CAS 461432-26-8) E CLORIDRATO METFORMINA (CAS 1115-70-4), UTILIZADO COMO MEDICAMENTO NO TRATAMENTO DE PACIENTES ADULTOS COM DIABETES MELITTUS TIPO 2 QUANDO O TRATAMENTO COM AMBOS COMPOSTOS E APROPRIADO. APRESENTADO NA FORMA DE COMPRIMIDOS REVESTIDOS DE LIBERACAO PROLONGADA CONTENDO 5MG/1000MG OU 10MG/500MG OU 10MG/1000MG DE DAPAGLIFLOZINA/CLORIDRATO DE METFORMINA EM EMBALAGEM COM 14 OU 30 OU 60 COMPRIMIDOS. PRINCIPIO ATIVO: CLORIDRATO DE METFORMINA (1000MG POR COMPRIMIDO REVESTIDO DE LIBERACAO PROLONGADA) E DAPAGLIFLOZINA (10MG POR COMPRIMIDO REVESTIDO DE LIBERACAO PROLONGADA), CATEGORIA: MEDICAMENTO ANTIDIABETICO - REGISTRO: 1161802620081 - VALIDADE: 10/2025 - APRESENTACAO: 10MG + 1000MG COM REV LIB PROL CT BL AL/AL X 30, PRODUTO ACABADO, EMBALADO EM CAIXAS DE PAPELAO - LOTE: WL0110 - FABRICACAO:07/08/2024 - VALIDADE: 31/07/2026 - NVE - AA - CAS/DCB - 0047-001115-70-4 (A BASE DE CLORIDRATO DE METFORMINA). APLICACAO: XIGDUO (CLORIDRATO DE METFORMINA & DAPAGLIFOSINA) E INDICADO NO TRATAMENTO DE DIABETES DO TIPO 2. | Brand | — | ||
| Quantity & Price | Amount | 316,251.60 | Weight | 3,682.30 kg | |
| Quantity | 28,800 CAIXAS | TEU | — | ||
| Shipment Information | Origin Country | UNITED STATES | Destination Country | BRAZIL | |
| Port of Loading | — | Destination Port | PORTO DE SANTOS | ||
| Loading Place | — | Transport Mode | SEA | ||
| Transaction Mode | DPU | Carrier | MAERSK MONTE ALEGRE | ||
| Vessel Name | MAERSK MONTE ALEGRE | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||